Your browser doesn't support javascript.
loading
The PDE1/5 Inhibitor SCH-51866 Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease.
Beaumont, Vahri; Park, Larry; Rassoulpour, Arash; Dijkman, Ulrike; Heikkinen, Taneli; Lehtimaki, Kimmo; Kontkanen, Outi; Al Nackkash, Rand; Bates, Gillian P; Gleyzes, Melanie; Steidl, Esther; Ramboz, Sylvie; Murphy, Carol; Beconi, Maria G; Dominguez, Celia; Munoz-Sanjuan, Ignacio.
  • Beaumont V; CHDI Management/CHDI Foundation, Los Angeles, California, USA.
  • Park L; CHDI Management/CHDI Foundation, Los Angeles, California, USA.
  • Rassoulpour A; Brains On-Line LLC, South San Francisco, California, USA.
  • Dijkman U; Brains On-Line LLC, South San Francisco, California, USA.
  • Heikkinen T; Charles River Discovery Research Services, Kuopio, Finland.
  • Lehtimaki K; Charles River Discovery Research Services, Kuopio, Finland.
  • Kontkanen O; Charles River Discovery Research Services, Kuopio, Finland.
  • Al Nackkash R; Department of Medical and Molecular Genetics, Kings College London, London, UK.
  • Bates GP; Department of Medical and Molecular Genetics, Kings College London, London, UK.
  • Gleyzes M; Neuroservice, Domaine de Saint Hilaire, 13593 Aix en Provence cedex 03, France.
  • Steidl E; Neuroservice, Domaine de Saint Hilaire, 13593 Aix en Provence cedex 03, France.
  • Ramboz S; PsychoGenics Inc., Tarrytown, New York, USA.
  • Murphy C; PsychoGenics Inc., Tarrytown, New York, USA.
  • Beconi MG; CHDI Management/CHDI Foundation, Los Angeles, California, USA.
  • Dominguez C; CHDI Management/CHDI Foundation, Los Angeles, California, USA.
  • Munoz-Sanjuan I; CHDI Management/CHDI Foundation, Los Angeles, California, USA.
PLoS Curr ; 62014 Feb 13.
Article en En | MEDLINE | ID: mdl-24558637